Factory 99% Anidulafungin Powder CAS 166663-25-8 Antifungal Anidulafungin

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A268
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Anidulafungin
• CAS: 166663-25-8
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Antifungal
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Anidulafungin
Appearance	White Powder
CAS NO.	166663-25-8
Molecular Formula	C52H73N13O18
Storage	Keep in a cool, dry, dark location

 

Anidulafungin is a semi-synthetic echinocandin derivative with potent antifungal activity. It belongs to a new class of antifungal agents that are specifically designed to target and inhibit the synthesis of β-1,3-glucan, a vital component of the fungal cell wall. By disrupting the integrity of the fungal cell wall, anidulafungin effectively kills or inhibits the growth of fungi. This medication is indicated for the treatment of various fungal infections, including candidemia, intra-abdominal abscesses, peritonitis, and esophageal candidiasis.

 

 

1. Therapeutic Use: Anidulafungin is primarily prescribed for the treatment of serious fungal infections that are resistant to conventional antifungal agents or require a more potent therapeutic option.
2. Medical Practice: Administered by healthcare professionals through intravenous infusion, typically once daily, as part of an antifungal treatment plan tailored to the patient's specific needs and infection severity.

1. Antifungal Activity: By inhibiting the synthesis of β-1,3-glucan, anidulafungin disrupts the structural integrity of the fungal cell wall, leading to fungal cell death and effective clearance of the infection.
2. Broad-Spectrum Coverage: Anidulafungin exhibits activity against a wide range of fungi, including Candida species, Aspergillus species, and other clinically relevant fungal pathogens, providing a therapeutic option for difficult-to-treat infections.